A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Acetaminophen Extended Release Caplets (3900 mg/Day) in the Treatment of Post-Race Muscle Aching and Pain (Soreness)
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 665
- 主要终点
- The average change from baseline in muscle soreness on Day 1
研究概览
简要总结
The purpose of this study is to compare the effectiveness of acetaminophen extended release caplets to placebo in treating the muscle aching and pain (soreness) that occurs after a marathon.
详细描述
This is a randomized, double-blind, placebo-controlled study to compare the effectiveness and safety of acetaminophen and placebo in treating muscle aching and pain (soreness) that occurs in subjects who complete a marathon. Subjects are randomized to receive acetaminophen extended release caplets, 3900 mg/day (two 650 mg caplets taken three times a day, for four days) or placebo (two placebo caplets taken three times a day, for four days). The primary measurement of efficacy is the average change from baseline in muscle soreness, on Day 1, the day of the marathon. Safety assessments consist of monitoring adverse events, and a physical examination at the screening visit, including vital signs, weight, a medical history review, and a urine pregnancy test for females of childbearing potential. The hypothesis of the study is that acetaminophen is more effective than placebo in the relief of post-race muscle aching and pain (soreness) score on the evening of the race. Two acetaminophen 650 mg extended release caplets, taken by mouth, three times a day over a four day period or two placebo caplets, taken by mouth, three times a day over a four day period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must be able to comply with the study schedule
- •be able to swallow the study medication
- •complete the marathon
- •not take any analgesics after completing the marathon and before their eligibility to participate in the study has been determined
- •rate their muscle soreness at least a 4, on a 0 - 10 point scale
排除标准
- •Previous diagnosis of osteoarthritis
- •currently have or have had a medical condition that may be relevant in one's eligibility to participate in the study
- •known hypersensitivity to acetaminophen
- •unable to understand or follow the instructions for the study
- •taken any investigational medication within 30 days of the marathon
研究组 & 干预措施
001
acetaminophen extended release
干预措施: acetaminophen extended release (Drug)
结局指标
主要结局
The average change from baseline in muscle soreness on Day 1
次要结局
- Average change from baseline in muscle soreness for both morning and evening assessments, combined and separately; Average ratings of interference with 1) sleep, 2) daily activity, and 3) ability to go for a run
